- Fee assured
- Awaiting verification
- Metabolic medicine
Prof. Massimo Pinzani (H-Index 60) is a Hepatologist with over 25 years of experience in the area of chronic liver diseases with high expertise in the cellular and molecular mechanisms of hepatic fibrogenesis and the development of biomarkers and other non invasive methods to assess liver tissue fibrosis. Prof. Pinzani moved to the UK in July 2012 as new UCL Sheila Sherlock Chair of Hepatology and Director of the UCL Institute for Liver and Digestive Health. He has served as board member in several international organisations and as associate editor/editor for international peer-reviewed journals. Prof. Pinzani’s research activity has been continuously funded since 1994 by national (Italy) and international organisations (EU frameworks).
Areas of interest
Chronic liver diseases, Liver Cirrhosis, Portal Hypertension, Metabolic liver diseases, Hepatocellular Carcinoma
Current NHS consultant posts held
Sheila Sherlock Chair of Hepatology and Director of the UCL Institute for Liver and Digestive Health. Honorary Consultant Hepatologist at the Royal free London and at UCLH.
Cell and molecular mechanism of hepatic and intestinal fibrogenesis (Crohn’s disease), development of biomarkers and technologies for the non invasive evaluation of disease progression in Hepatology, regenerative Hepatology (preparation of bio-scaffold by flow decellularization and repopulation with inducible pluripotent stem cells), tissue biology and biophysics of cirrhotic liver.
Over 200 original articles in peer reviewed international journals (PubMed). Cumulative H Index 64